| Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection C Phetsouphanh, DR Darley, DB Wilson, A Howe, C Munier, SK Patel, ... Nature immunology 23 (2), 210-216, 2022 | 901 | 2022 |
| The transforming growth factor-β superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women AG Moore, DA Brown, WD Fairlie, AR Bauskin, PK Brown, MLC Munier, ... The Journal of Clinical Endocrinology & Metabolism 85 (12), 4781-4788, 2000 | 307 | 2000 |
| Cytotoxic CD4 T cells—friend or foe during viral infection? JA Juno, D Van Bockel, SJ Kent, AD Kelleher, JJ Zaunders, CML Munier Frontiers in immunology 8, 19, 2017 | 225 | 2017 |
| Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection JJ Zaunders, WB Dyer, B Wang, ML Munier, M Miranda-Saksena, ... Blood 103 (6), 2238-2247, 2004 | 220 | 2004 |
| High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40) JJ Zaunders, ML Munier, N Seddiki, S Pett, S Ip, M Bailey, Y Xu, K Brown, ... The Journal of Immunology 183 (4), 2827-2836, 2009 | 207 | 2009 |
| Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over‐active CD4+ T‐cell responses in HIV‐positive patients with mycobacterial … N Seddiki, SC Sasson, B Santner‐Nanan, M Munier, D van Bockel, S Ip, ... European journal of immunology 39 (2), 391-403, 2009 | 164 | 2009 |
| Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary … JJ Zaunders, S Ip, ML Munier, DE Kaufmann, K Suzuki, C Brereton, ... Journal of virology 80 (20), 10162-10172, 2006 | 130 | 2006 |
| Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes I Moran, A Nguyen, WH Khoo, D Butt, K Bourne, C Young, JR Hermes, ... Nature communications 9 (1), 3372, 2018 | 115 | 2018 |
| Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection JJ Zaunders, ML Munier, DE Kaufmann, S Ip, P Grey, D Smith, ... Blood 106 (5), 1660-1667, 2005 | 114 | 2005 |
| Acutely dysregulated, chronically disabled by the enemy within: T‐cell responses to HIV‐1 infection ML Munier, AD Kelleher Immunology and cell biology 85 (1), 6-15, 2007 | 101 | 2007 |
| SARS-CoV-2 Omicron BA. 5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern A Aggarwal, A Akerman, V Milogiannakis, MR Silva, G Walker, AO Stella, ... EBioMedicine 84, 2022 | 94 | 2022 |
| HIV vaccines: progress to date CM Ling Munier, CR Andersen, AD Kelleher Drugs 71, 387-414, 2011 | 89 | 2011 |
| Circulating gluten-specific FOXP3+ CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease L Cook, CML Munier, N Seddiki, D van Bockel, N Ontiveros, MY Hardy, ... Journal of Allergy and Clinical Immunology 140 (6), 1592-1603. e8, 2017 | 88 | 2017 |
| A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1 AD Kelleher, RL Puls, M Bebbington, D Boyle, R Ffrench, SJ Kent, ... Aids 20 (2), 294-297, 2006 | 82 | 2006 |
| CD127+ CCR5+ CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells JJ Zaunders, WB Dyer, ML Munier, S Ip, J Liu, E Amyes, W Rawlinson, ... Journal of virology 80 (20), 10151-10161, 2006 | 79 | 2006 |
| Human antigen‐specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses N Seddiki, L Cook, DC Hsu, C Phetsouphanh, K Brown, Y Xu, SJ Kerr, ... European journal of immunology 44 (6), 1644-1661, 2014 | 74 | 2014 |
| Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response DJ van Bockel, DA Price, ML Munier, V Venturi, TE Asher, K Ladell, ... The Journal of Immunology 186 (1), 359-371, 2011 | 70 | 2011 |
| SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern A Aggarwal, AO Stella, G Walker, A Akerman, V Milogiannakis, F Brilot, ... medrxiv, 2021.12. 14.21267772, 2021 | 64 | 2021 |
| IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers SC Sasson, S Smith, N Seddiki, JJ Zaunders, A Bryant, KK Koelsch, ... Cytokine 50 (1), 58-68, 2010 | 51 | 2010 |
| Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing D Van Bockel, CML Munier, S Turville, SG Badman, G Walker, AO Stella, ... Viruses 12 (11), 1208, 2020 | 45 | 2020 |
John ZaundersSenior Scientist, St Vincent's Hospital, Sydney Verified email at amr.org.au
